Katherine Reed, MD
Dermatology · Spokane, WANPI 1396919569
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 250 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by AbbVie at 30.4% of the total. 2025 is the largest year on record at $1,170, 2.1 times the $547 reported in 2019.
Across 250 payments — averaging $17.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Lilly USA, LLC$684
- Johnson & Johnson$291
- Sanofi$274
- Pfizer$249
- Galderma Laboratories, L.p.$241
- plus $1K from 20 others
Across 1,162 payments — averaging $2646.43 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Incyte Corporation$1.3M
- Eli Lilly$594K
- AbbVie$413K
- Kiniksa Pharmaceuticals, Ltd.$241K
- Pfizer$214K
- Amgen$85K
- plus $230K from 9 others
What the payments were for
- Food & beverage$4,41399%
- Education$301%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 66 | $1,349 |
| Lilly USA, LLC | 38 | $684 |
| Johnson & Johnson | 18 | $291 |
| Sanofi | 12 | $274 |
| Pfizer | 21 | $249 |
| Galderma Laboratories, L.p. | 21 | $241 |
| Novartis | 13 | $203 |
| Amgen | 10 | $176 |
| Arcutis Biotherapeutics, Inc. | 8 | $130 |
| LEO Pharma Inc. | 5 | $110 |
| Dermavant Sciences, Inc. | 6 | $106 |
| Regeneron Healthcare Solutions, Inc. | 5 | $105 |
| UCB, Inc. | 6 | $105 |
| Sun Pharmaceutical Industries Inc. | 3 | $77 |
| Incyte Corporation | 3 | $55 |
| Bristol Myers Squibb | 2 | $48 |
| Boehringer Ingelheim | 2 | $48 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $29 |
| Biofrontera Inc. | 2 | $29 |
| Integra Lifesciences Corporation | 1 | $25 |
| Kyowa Kirin, Inc. | 1 | $24 |
| Krystal Biotech Inc | 1 | $20 |
| Organon | 1 | $18 |
| Next Science LLC | 1 | $18 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $16 |
| Prugen, Inc. Pharmaceuticals | 1 | $14 |
How this compares
$4,443 in reported general payments places this provider in the 75th percentile of 323 dermatology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 12 | $192,779 |
| Dupixent PenDupilumab | 39 | $165,061 |
| Taltz AutoinjectorIxekizumab | 14 | $96,004 |
| Dupixent SyringeDupilumab | 12 | $52,850 |
| Clobetasol Propionate | 136 | $6,581 |
| Ketoconazole | 144 | $2,321 |
| Metronidazole | 32 | $1,426 |
| Tretinoin | 16 | $1,398 |
| Tacrolimus | 15 | $1,375 |
| Finasteride | 121 | $1,277 |
| Minoxidil | 98 | $1,260 |
| Dapsone | 16 | $1,138 |
| Clindamycin Phosphate | 30 | $1,124 |
| Betamethasone Dipropionate | 31 | $1,081 |
| ValacyclovirValacyclovir Hcl | 53 | $913 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Spokane
- William WerschlerSpokane$948K
- Cameron ChesnutSpokane$93K
- Joyce ParkSpokane$8K
- James ParkerSpokane$7K
- William WraySpokane$6K
- Brittany UrsoSpokane$5K
- Clive LiuBellevue$2.9M
- Vivian ShiSeattle$971K
- Daniel LevyBonney Lake$541K
- Daniel SugaiBellevue$302K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.